Previous studies of 21q deletions, including RUNX1, describe thrombocytopenia and predisposition to myeloid malignancies, while separate reports of SON loss-of-function variants reproduce the core ZTTK neurodevelopmental phenotype, together supporting the pathogenicity of the present contiguous deletion [18]. This evidence concerns the gene RUNX1 and myeloid neoplasm.